{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Neuroleptic Malignant Syndrome: A Case Report

Activity Steps

Purpose of Activity

To provide information on the identification and treatment of NMS.

Learning Objectives

After completing this continuing education activity you will be able to:

  1. Identify the clinical manifestations of NMS.
  2. List the risk factors for NMS.
  3. Summarize treatment options for patients with NMS.
Price: $17.95

Credits:

  • ANCC 1.5 CH / 0.5 APH
  • DC - BON 1.5 CH
  • FL - BON 1.5 CH
  • GA - BON 1.5 CH

Lippincott Professional Development is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation. This activity is also provider approved by the California Board of Registered Nursing, Provider Number CEP 11749. Lippincott Professional Development is also an approved provider of continuing nursing education by the District of Columbia Board of Nursing, Florida Board of Nursing, Georgia Board of Nursing, New Mexico Board of Nursing, South Carolina Board of Nursing, and West Virginia Board of Examiners for Registered Professional Nurses, #50-1223.

Awarded Advanced Pharmacology Hours







Test Code: N0420A
Published: Apr 2020
Expires: 6/7/2024
Sources: Nursing2024
Required Passing Score: 15/19 (78%)
Authors: Lisa A. Ruth-Sahd DEd, RN, CCRN, CEN, CNE; Darris Rodrigues BSN, RN; Elizabeth Shreve